Table 2. . Percent inhibition of cancer cell line proliferation in the presence of compounds (1 µM).
Compound | HSM1692 | HSN136 | HSN129 | HSN99 | HSM1661 | HSM1688 | HSN161 | HSN189 | HSM1751 | HSN157 | HSN174 | HSM1717 | HSN247 | HSN248 | HSN178 | HSN185 | HSN315 | HSN286 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Code | A25 | A26 | A27 | A28 | A29 | B8 | B15 | B16 | B17 | B20 | B22 | C10 | D6 | D7 | D15 | D16 | D28 | D30 |
MV-4–11 | 81 | 86 | 99 | 97 | 90 | 74 | 97 | 95 | 91 | 96 | 85 | 82 | 58 | 98 | 98 | 97 | 83 | 99 |
HCT116 | 29 | 38 | 29 | 20 | 0 | 43 | 18 | 7 | 32 | 12 | 28 | 33 | 54 | 76 | 97 | 67 | 66 | 100 |
HeLa | 0 | 0 | 22 | 6 | 1 | 64 | 70 | 18 | 23 | 33 | 10 | 2 | 100 | 100 | 100 | 99 | 100 | 100 |
MCF-7 | 22 | 33 | 37 | 42 | 96 | 33 | 91 | 49 | 47 | 21 | 40 | 76 | 100 | 100 | 100 | 100 | 100 | 100 |